Rice William G. 4
4 · Aptose Biosciences Inc. · Filed Jul 7, 2022
Insider Transaction Report
Form 4
Rice William G.
DirectorChair, President & CEO
Transactions
- Award
Performance Stock Options
2022-07-06+600,000→ 600,000 totalExercise: $0.81Exp: 2032-07-06→ Common Shares (600,000 underlying)
Footnotes (1)
- [F1]Represents performance stock options granted on July 6, 2022, which vest in tranches upon the achievement of specified performance events. Settlement of vested performance stock options will occur as soon as practicable following vesting. This grant is being reported voluntarily.